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Abstract: The EMCDDA has estimated annual 
public expenditure on drug-law offenders in 
prisons in Europe. Between 2000 and 2010, this 
expenditure is estimated to have been within the 
range of 0.03 % to 0.05 % of GDP, on average, in 
22 European countries. By applying these 
percentages to the whole EU for the year 2010, it 
can be estimated that the expenditure was within 
the range of EUR 3.7 billion to EUR 5.9 billion. 
Based on data provided by Eurostat and the 
Council of Europe, the proportion of sentenced 
prisoners who have a drug-law offence as their 
main offence was applied to total public 
expenditure on prisons. A range of estimates was 
calculated, with low estimates considering only 
those prisoners sentenced for a drug-law offence 
and high estimates also including pre-trial 
prisoners. The estimates were limited by the data 
available. Data are missing for 8 of the 30 
countries that participate in the EMCDDA’s 
network: in some countries, penal statistics do 
not apply the ‘main offence rule’; and data on the 
lengths of periods of imprisonment and the 
proportion of drug-law offenders under special 
security measures are not available. For the sake 
of accuracy, more complete data sets would be a 
valuable asset.
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provide countries with examples of simple tools which could 
be of use when constructing national estimates of drug-
related public expenditure, taking into account the limited 
data available and the need to use a methodology that will 
enable comparisons across countries. The second aim is to 
facilitate a common understanding of how much is spent on 
different areas of drug policy in Europe, and the third is to 
stimulate a constructive and pragmatic debate among 
researchers. Where possible, we prioritise the use of existing 
European databases and successfully tested methodologies.
This study estimates how much 22 European countries spent 
on drug-law offenders in prisons during the last decade. 
Based on this, an estimate for public expenditure on drug-law 
offenders at the European level was made. In order to attain 
this objective, the study identifies suitable data sets and 
suggests a simple model, taking into account the scarcity of 
available data. This exercise may be used as an example for 
similar exercises. However, it also highlights some areas where 
additional data would be useful, allowing important 
methodological improvements and more accurate estimates. 
Because of the current data limitations, results and analysis 
need to be viewed with caution; conclusions provided are 
useful mainly for discussion purposes.
I Available data
In order to estimate public expenditure on drug-law offenders 
in prison, the EMCDDA has opted for a top-down approach, 
which aims to disentangle the funds allocated to a specific 
drug policy from the overall public budget (3). As Vander 
Laenen et al. (2008) remark, a top-down approach is 
commonly used in analyses of drug-related public 
expenditure, as drug-related expenditures are often 
‘unlabelled’ because they are embedded in broader policy 
domains. A top-down approach is suitable for estimating 
expenditure on drug-law offenders in prison because such 
spending is part of the broader prisons budget.
(3)  A top-down approach was chosen because, according to the available 
information, it seemed that this is the approach that can most feasibly be 
applied to other areas of drug policy (such as, police services and law courts).
I Introduction
Estimating drug-related public expenditure and developing the 
economic monitoring of drug policy have been on the 
European agenda for more than a decade (1). However, until 
now only 17 countries out of the 30 followed by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
have produced one or more comprehensive estimates of the 
government’s expenditure on implementing drug policy (2). 
Furthermore, those who have done so have most often used 
non-comparable methodologies. As a consequence, the 
economic monitoring of drug policy is still in its infancy in 
Europe.
Over the past few years, the EMCDDA has supported and 
promoted the development of national estimates of drug-
related public expenditure in EU Member States. This has 
contributed to an increase in the number of such estimates 
but has also highlighted several methodological and practical 
difficulties that need particular attention. Estimating drug-
related public expenditure poses a series of challenges. One is 
that only a small part of drug-related public expenditure can 
be traced back directly to a government’s budget and 
accountancy documents. The larger part is embedded in 
broader expenditure categories (e.g. police services or 
hospitals) and needs to be estimated with the help of models 
and secondary data sets. This type of expenditure is 
commonly referred to as ‘unlabelled expenditure’ (EMCDDA, 
2008). Another challenge is that when a country develops a 
national estimate of drug-related public expenditure it often 
does not have access to the full desired data set. When this 
exercise is transposed to the European level, the availability of 
comparable and harmonised data becomes even more 
limited. Therefore, to develop an estimate of drug-related 
public expenditure across Europe it is necessary to define a 
model that best estimates each type of drug-related public 
expenditure, taking into account these restrictions.
This publication is the first on developing strategies for 
estimating different components of drug-related public 
expenditure in Europe. Its aims are threefold. The first is to 
(1)  Council of the European Union (2005) EU drugs action plan (2005–08), 
Cordrogue 25, Brussels, 19 May 2005.
(2)  Further information is available at http://www.emcdda.europa.eu/topics/
drug-related-public-expenditure.
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Data availability is a key element in the choice of the method. 
The method chosen needs to be feasible for application to the 
majority of European countries and, furthermore, using 
comparable data. The best available European database on 
public expenditure, in which the funds allocated to various 
public policy objectives are estimated, has been developed by 
Eurostat. Its categorisation system is based on the 
international Classification of the Functions of Government 
(COFOG) system (4). The main strengths of this database are 
that it provides annual data on public expenditure 
disaggregated by policy area, that is, according to the purpose 
of the spending. Additionally, submission of data is mandatory 
and is managed by Eurostat and national statistical institutes, 
and the data are therefore subject to systematic control and 
validation procedures. The main limitations are that classifying 
expenditures according to a single purpose is sometimes 
reductionist and the categories can be interpreted differently 
by different data providers. There is still room for improvement 
in order to further harmonise definitions and accountancy 
practices.
The second data source used in this study was the Annual 
Penal Statistics of the Council of Europe or SPACE (Aebi and 
Delgrande, 2012). This project provides data on the 
populations detained in penal institutions across Europe. In 
2012, it published data for 47 Member States of the Council of 
Europe. These countries registered 52 prison administrations 
(4)  http://epp.eurostat.ec.europa.eu/cache/ITY_SDDS/EN/gov_a_exp_esms.htm
Estimates of public expenditure on drug-law offenders in 
prison are part of a broader field of analysis relating to 
the social cost of drug-related crime.
As Brand and Price (2000) stressed, in this field social 
costs are multiple and borne by both the public and the 
private sector. While public-sector costs might be 
related, for instance, to the public funding of prisons, 
private costs might include the reduction in a family’s 
income due to an offender losing his or her job. Vander 
Laenen at al. (2008) argued that these social costs are 
also borne by the community as a whole and proposed 
the use of the expression ‘external costs’. An example of 
an external cost would be the negative impact of prisons 
on their neighbourhoods. Neighbourhoods close to 
prisons can be considered less safe, resulting in a 
reduction the value of the property in the area. 
Drug-law offences are only one specific type of drug 
crime. There are four main types of drug-related crime 
(EMCDDA, 2007). First, psychopharmacological crimes, 
i.e. crimes committed under the influence of a 
psychoactive substance, as a result of its acute or 
chronic use; second, economic-compulsive crimes, i.e. 
crimes committed in order to support drug use, i.e. to 
obtain drugs or means of payment for drugs; third, 
systemic crimes, i.e. crimes committed within the 
functioning of illicit drug markets, as part of the business 
of drug supply, distribution and use; and, fourth, drug-law 
offences, i.e. crimes committed in violation of drug (and 
other related) legislation.
There is widespread interest among researchers and 
policymakers in estimating the full social costs of 
drug-related crime; however, comparable international 
data do not exist on either private or external costs. The 
scarcity of data also explains restrictions on the type of 
drug-related crime analysed in this study. Data on 
psychopharmacological crimes, economic-compulsive 
crimes and systemic crimes are rare and often 
inadequate at European level. All in all, the confined 
scope of this analysis aims that estimates produce 
reliable, comparable and representative European 
results, and these characteristics should be the strength 
of this analysis.
Expenditure on drug-law offenders in prison 
versus the social costs of drug crime
Eurostat publishes annual data on total general 
government public expenditure that includes data on 
central, regional and local government expenditure as 
well as social security spending. Expenditure is broken 
down by the governments’ main socioeconomic 
functions (according to COFOG). Eurostat has been 
reporting these data for the EU-27 countries since 2002.
COFOG has two levels of classification (United Nations, 
2008). The first one classifies expenditure in 10 general 
functions, one of which is ‘Public order and safety’. The 
second level classifies expenditure in 69 groups, and 
one of these is ‘Prisons’. This concerns public spending 
on ‘Administration, operation or support of prisons and 
other places for the detention or rehabilitation of 
criminals such as prison farms, workhouses, 
reformatories, borstals, asylums for the criminally 
insane, etc.’
Public expenditure breakdown by objectives: 
the COFOG system
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instance); data on the average length of prison stay according 
to the type of main offence (average length for drug-law 
offences compared with average length for other types of 
offence); data on the main offence for which pre-trial prisoners 
are prosecuted; and data on drug-law offenders under special 
conditions (such as electronic supervision) or special security 
measures.
I Key figures on Europe’s prison population
In 2010, there were 627 203 prisoners in the EU-27, 
corresponding to 0.13 % of the total population (see Table 1). 
Of these, 487 356 were sentenced, representing 77.7 % of the 
total prison population, while the remainder were pre-trial. The 
proportion of sentenced prisoners to the total prison 
population varied significantly between countries, 
representing more than 80 % in some countries and less than 
50 % in others.
The numbers of sentenced drug-law offenders in prison per 
country over the period 2000–10 are illustrated in Annex 1.
In 2010, among the sentenced prisoners in 25 EU countries 
(data are not available for Austria and Poland), 18.5 % were 
sentenced for a drug-law offence. This proportion varied 
widely between countries, from about 50 % in Greece to less 
than 5 % in Romania, Hungary and Lithuania.
The proportion of sentenced drug-law offenders in the total 
prison population (sentenced and pre-trial prisoners) was 
13.9 % in 2010. Again, this proportion varied markedly from 
country to country. Countries with the highest proportions of 
sentenced drug-law offenders relative to the total number of 
prisoners were those which combined higher rates of 
sentenced prisoners with higher rates of sentenced drug-law 
offenders.
under their control, and 46 of these prison administrations 
replied to the SPACE questionnaire (5). Data are available for 
the EU-27 countries for the period 2000–10, with increasing 
data coverage.
SPACE data include both the total numbers of prisoners and 
various breakdowns of these figures. Two of these are 
particularly relevant for this study. The first is the breakdown 
by the legal status of prisoner. For simplicity, this report 
follows the SPACE project in referring to two broad categories: 
‘pre-trial’ prisoners (untried, awaiting a court decision; 
convicted but not yet sentenced; sentenced but who have 
appealed or who are within the statutory limits for doing so) 
and ‘sentenced’ prisoners (those who have received their final 
sentence). The second relevant SPACE data breakdown is by 
10 types of offence for which prisoners have been sentenced 
(i.e. received their final sentence) as the main offence; one of 
these types is ‘drug offences’. Unfortunately, this breakdown is 
not available for pre-trial prisoners, and a further breakdown 
according to the type of drug offence is not available for 
sentenced prisoners.
In this report, all references to offence types are to main 
offences and prisoners sentenced for drug offences will be 
referred to as ‘drug-law offenders’. There are, however, some 
limitations associated with the features and registration 
systems of the different criminal justice systems (Aebi et al., 
2007). For example, in 2009 the main offence rule was not 
well defined in Belgium, Bulgaria, Lithuania, Malta or Poland, 
and prisoners sentenced for more than one offence could be 
counted several times. In 2010, this limitation was reported 
only in Belgium, Bulgaria and the Czech Republic.
Additional data would be required to improve the accuracy of 
estimates. This could include data on the different types of 
drug offences for which prisoners were sentenced 
(distinguishing drug trafficking from drug consumption, for 
(5)  In 2012, prison administrations of four EU Member States did not answer 
SPACE’s 2010 questionnaire: Belgium, Bulgaria, Malta and the United 
Kingdom (England and Wales). 
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TABLE 1
Total prison population and drug-law offenders in prison
2003–07 2008 2009 2010
Prison population in Europe (27) (1),(2) 596 956 623 230 641 845 627 203
Prison population rate in Europe 0.12 % 0.13 % 0.13 % 0.13 %
Highest prison population rates
Lithuania 0.25 % 0.23 % 0.25 % 0.27 %
Latvia 0.33 % 0.29 % 0.31 % 0.30 %
Estonia 0.34 % 0.27 % 0.27 % 0.26 %
Lowest prison population rates
Denmark 0.07 % 0.06 % 0.07 % 0.07 %
Slovenia 0.06 % 0.07 % 0.07 % 0.07 %
Finland 0.07 % 0.07 % 0.07 % 0.06 %
Proportion of sentenced prisoners among total prisoners in 
Europe (1),(3)
73.8 % 74.4 % 75.3 % 77.7 %
Highest proportions of sentenced prisoners
Czech Republic 84.9 % 88.3 % 89.2 % 88.8 %
Poland 80.0 % 88.4 % 88.2 % 89.0 %
Romania 84.8 % 89.1 % 85.4 % 82.9 %
Lowest proportions of sentenced prisoners
Malta 50.4 % 30.7 % 36.0 % 30.5 %
Netherlands 37.3 % 35.4 % 36.5 % 49.6 %
Italy 56.8 % 43.6 % 49.3 % 54.2 %
Proportion of sentenced drug-law offenders among total sentenced 
prisoners in Europe (4),(5)
17.6 % 17.6 % 17.6 % 18.5 %
Highest proportions of drug-law offenders
Malta 32.5 % — 53.4 % —
Greece 50.6 % — — 52.3 %
Italy 33.5 % 36.1 % 36.9 % 38.4 %
Luxembourg 31.9 % 44.6 % 38.7 % 36.1 %
Lowest proportions of drug-law offenders
Lithuania  4.6 %  6.5 %  8.4 %  1.0 %
Hungary  1.9 %  2.5 %  2.6 %  3.1 %
Romania  2.5 %  4.0 %  4.2 %  4.3 %
Proportion of sentenced drug-law offenders among total prisoners 
in Europe (4) (sentenced and pre-trial) 
12.5 % 12.1 % 12.5 % 13.9 %
Highest proportions of drug-law offenders
Greece 37.3 % — — 36.0 %
Luxembourg 19.8 % 26.4 % 21.9 % 20.7 %
Sweden 18.4 % 24.1 % 22.9 % 22.1 %
Lowest proportions of drug-offenders
Hungary  1.4 %  1.7 %  1.8 %  2.1 %
Romania  1.9 %  3.6 %  3.6 %  3.6 %
Slovakia  2.3 % —  5.1 %  4.6 %
Data source: SPACE I Project, Council of Europe Annual Penal Statistics.
(1) Total number of prisoners (pre-trial and sentenced prisoners) on 1 September.
(2) In 2010, data for Belgium and England and Wales concern 2009.
(3) In 2010, data for Austria, Belgium and England and Wales concern 2009. Data missing for other years have been interpolated from adjacent years.
(4) ‘Europe’ refers to the weighted average for EU-27 (excluding Austria and Poland).
(5) The proportion of sentenced drug-law offenders among the total sentenced prisoners on 1 September.
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Public expenditure on prisons represented, on average, about 
0.18 % of EU-27 (7) GDP, between 2003 and 2007. After 
2008, this share declined slightly. Interestingly, during the 
economic recession of 2008 the reduction in the public 
spending on prisons was bigger than the reduction in the EU’s 
GDP. Therefore, the proportion of GDP spent on prisons 
tended to fall.
However, when public expenditure by prisoner (sentenced and 
pre-trial) is analysed, data show that, after the decline 
observed in 2009, expenditure per prisoner increased in 2010, 
although it did not reach the level of 2008.
(7)  In July 2012, Eurostat published statistics on public expenditure on prisons 
for 23 countries, with data up to 2010. These countries were the EU-27 
excluding Belgium, France, Romania and Slovakia.
I  Key figures on public expenditure on prisons in Europe
Table 2 shows that, in the period 2003–10, EU-27 
governments allocated about half of their countries’ annual 
gross domestic product (GDP) to government spending. 
Funds spent on the objective ‘Public order and safety’ 
amounted, at most, to 2 % of GDP (6). Those countries which 
spent the highest proportions of their GDP on public order and 
safety spent about twice as much as those which spent the 
smallest proportions.
Between 2003 and 2008, EU-27 expenditure remained stable 
at 1.8 % of GDP. In 2009, it increased slightly in nominal 
terms. There was a marked fall in the EU’s GDP in 2009, and 
the proportion of public expenditure on public order and 
safety increased marginally, a situation which was partially 
reversed in 2010.
(6)  Public expenditure on ‘Public order and safety’ is defined according to the 
COFOG system of public accountancy. 
In 2010, total public expenditure of the general government 
amounted to 50.6 % of GDP in the European Union. This 
represents an increase compared with the period 2003–09 
(47.2 % of GDP). A breakdown by socioeconomic functions 
shows that in 2010 social protection represented the 
largest share of public expenditure, close to 20 % of GDP. 
Health absorbed the second-largest share (7.5 % of GDP), 
while the share of public order and safety was close to 2 % 
of GDP.
Public expenditure by main function in the EU-27  
(as a percentage of GDP)
2003–09 2010 
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TABLE 2
Public expenditure on public order and safety and on prisons (as a percentage of GDP)
2003–07 2008 2009 2010
Public expenditure in EU-27 46.5 47.1 51.1 50.6
Public expenditure on public order and safety EU-27 1.8 1.8 2.0 1.9
Highest proportions
United Kingdom 2.5 2.6 2.8 2.6
Latvia 2.5 2.3 2.1 2.0
Bulgaria 2.8 2.8 3.0 2.7
Lowest proportions
Luxembourg 1.0 0.9 1.0 1.0
Denmark 1.0 1.1 1.2 1.1
Finland 1.3 1.3 1.5 1.5
Public expenditure on prisons EU-27-4 (1) 0.18 0.18 0.17 0.16
Highest proportions
Sweden 0.21 0.22 0.25 0.23
United Kingdom 0.32 0.35 0.36 0.37
Netherlands 0.35 0.41 0.44 0.42
Lowest proportions
Greece 0.06 0.12 0.07 0.06
Germany 0.11 0.10 0.10 0.10
Cyprus 0.09 0.10 0.10 0.11
Public expenditure on prisons per prisoner EU-27-4 (1) 0.000045 0.000053 0.000051 0.000052
Highest proportions
Sweden 0.0001 0.0001 0.0002 0.0001
United Kingdom 0.0001 0.0001 0.0001 0.0001
Netherlands 0.0002 0.0003 0.0003 0.0004
Lowest proportions
Germany 0.000001 0.000001 0.000001 0.000001
Poland 0.000002 0.000002 0.000002 0.000002
Spain 0.000002 0.000002 0.000002 0.000003
Data source: Eurostat and Council of Europe.
(1)  Weighted average of public expenditure on prisons in the EU-27-4, i.e. the 27 European countries excluding Belgium, France, Romania and Slovakia, for which data 
are not available.
I  Estimating public expenditure on drug-law offenders in prison
Public expenditure on drug-law offenders in prison will be 
estimated by applying the proportion of prisoners sentenced 
for a drug-law offence to the national public expenditure on 
prisons of the EU countries. This method has significant 
limitations, stemming from the lack of available data. For 
instance, it does not take into account differences in the 
lengths of periods of imprisonment, or the proportion of 
drug-law offenders under special security measures, or other 
factors that would result in detention costs differing from 
those of other types of offence. These limitations reduce the 
accuracy of results but allow the comparison of results for 
most European countries.
Given these data limitations, two feasible estimates will be 
made: a low and a high estimate. The low estimate is based on 
the proportion of sentenced drug-law offenders of the total 
(sentenced and pre-trial) prison population. The high estimate 
is based on the proportion of sentenced drug-law offenders of 
the total sentenced prisoners (therefore excluding pre-trial 
prisoners). These estimates will be made for the 22 European 
countries that provided sufficient data for the period  
2000–10 (8).
(8)  These countries are Bulgaria, the Czech Republic, Cyprus, Denmark, Estonia, 
Finland, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, 
Luxemburg, Malta, the Netherlands, Norway, Portugal, Slovenia, Spain, 
Sweden and the UK. 
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I Low estimate
The low estimate of public expenditure on drug-law offenders 
in prison accounts for expenditure on sentenced drug-law 
offenders in prison. Therefore, it does not account for 
expenditure on pre-trial drug-law offenders.
During the period 2000–10, given the available data from 22 
European countries, the estimated public expenditure on 
sentenced drug-law offenders in prison represented, on 
average, 0.03 % of GDP among these countries, as illustrated 
in Table 3.
If applied to these countries’ GDP in 2010, this average of 
0.03 % of GDP would represent a public expenditure on 
sentenced drug-law offenders in prison of EUR 3.4 billion.
If it is assumed that there is no significant difference between 
these 22 countries and the EU-27 Member States, and if this 
average (0.03 % of GDP) is applied to the EU-27 GDP for 2010, 
then the low estimate of public expenditure on sentenced 
drug-law offenders in prisons in the EU-27 would be close to 
EUR 3.7 billion.
As can be seen from Table 3, disregarding the first two 
years (9), between 2002 and 2010 the average estimate was 
relatively stable, varying between 0.026 % and 0.032 % of 
GDP.
The change in value (both in nominal and real terms, as well as 
in percentage of GDP) over time of public expenditure on 
drug-law offenders in prison varies markedly in a country-by-
country analysis, as shown in Annex 2 and Annex 3.
Table 3 shows that, when the low-estimate method is applied, 
estimates for most of the 22 countries of public expenditure 
on sentenced drug-law offenders in prison during the period 
2000–10 are between 0.01 % and 0.03 % of GDP. Four 
countries have an estimate below 0.01 % of GDP (Bulgaria, 
Lithuania, Hungary and Slovenia) and six have an estimate 
above 0.03 % of GDP (Ireland, Italy, Malta, Portugal, Sweden 
and the United Kingdom). Such differences reflect national 
characteristics affecting public expenditure on prisons: 
different crime rates, different legal frameworks and judicial 
systems, different sentencing practices and also different 
proportions of pre-trial prisoners in the total population.
(9)  Eurostat started publishing data for public expenditure on prisons in 2000. 
However, in 2000 and 2001, only a small number of countries reported data.
Equations (1), (2) and (3) represent the simple model 
used to estimate national public expenditure on drug-
law offenders in prison.
P
PEX  i,t
 = a
i,t
 × T
PEX i,t
 (1)
a
i,t
 = ———— (2)
a
i,t
 = ———— (3)
P
PEX  i,t
 is public expenditure on drug-law offenders in 
prison in country i and year t, T
PEX i,t
 is total public 
expenditure on prisons in country i and period t. Using aA 
we arrive at the low estimate. aA is the proportion of 
sentenced drug-law offenders in prison relative to the 
total number of prisoners (sentenced and pre-trial) in 
country i and year t. Therefore, N
i,t
 DLO is the number of 
sentenced drug-law offenders in prison in country i and 
year t, and N
i,t
  is the total number of prisoners in country 
i and year t. Using aB we arrive at the high estimate. aB is 
the proportion of sentenced drug-law offenders and 
pre-trial drug-law offenders to the total prisoners in 
country i and year t.
DLO
A
B
DLO
A
TD
A simple model for estimating public 
expenditure on drug-law offenders in prison
N
i,t
 DLOA
N
i,t
TD
N
i,t
 DLOB
N
i,t
TD
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TABLE 3
Estimated public expenditure on sentenced drug-law offenders in prison (as a percentage of GDP)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Average 
(2000–10)
Bulgaria 0.001 0.001 0.003 0.007 0.009 0.007 0.009 0.009 0.006
Czech Republic 0.008 0.010 0.014 0.014 0.021 0.013 0.011 0.013
Denmark 0.022 0.023 0.021 0.025 0.029 0.027 0.028 0.026 0.028 0.024 0.025
Germany 0.013 0.013 0.013 0.013 0.013 0.012 0.013 0.013 0.013 0.013
Estonia 0.003 0.011 0.027 0.011 0.012 0.012 0.017 0.067 0.039 0.030 0.023
Ireland 0.027 0.036 0.025 0.030 0.038 0.046 0.043 0.035
Greece 0.014 0.027 0.022 0.021
Spain 0.026 0.030 0.027 0.025 0.021 0.024 0.026 0.026 0.028 0.029 0.038 0.027
Italy 0.047 0.046 0.049 0.055 0.052 0.051 0.028 0.026 0.036 0.041 0.047 0.043
Cyprus 0.012 0.011 0.010 0.014 0.019 0.021 0.016 0.015 0.017 0.015
Latvia 0.021 0.020 0.020 0.017 0.020
Lithuania 0.005 0.005 0.008 0.007 0.009 0.008 0.008 0.010 0.012 0.016 0.002 0.008
Luxembourg 0.014 0.016 0.014 0.009 0.012 0.024 0.026 0.026 0.028 0.027 0.024 0.020
Hungary 0.001 0.002 0.004 0.003 0.002 0.003 0.003 0.004 0.003
Malta 0.049 0.058 0.037 0.039 0.029 0.030 0.026 0.038
Netherlands 0.031 0.031 0.030 0.024 0.025 0.025 0.029 0.029 0.036 0.029
Portugal 0.052 0.055 0.056 0.040 0.037 0.037 0.028 0.030 0.031 0.041
Slovenia 0.007 0.006 0.007 0.006 0.007 0.007 0.007 0.007 0.006 0.006 0.007 0.007
Finland 0.020 0.020 0.021 0.018 0.017 0.015 0.017 0.016 0.016 0.018
Sweden 0.032 0.037 0.038 0.038 0.041 0.038 0.042 0.054 0.058 0.052 0.043
United Kingdom (total) 0.035 0.036 0.033 0.040 0.043 0.045 0.042 0.045 0.045 0.045 0.046 0.041
Norway 0.025 0.025 0.033 0.026 0.025 0.024 0.035 0.025 0.031 0.024 0.027
Median 0.01 0.03 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.02 0.025
Average 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.02 0.024
Weighted average 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.030
Standard deviation 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.01 0.01
Coefficient of variation 0.9 0.8 0.7 0.7 0.7 0.6 0.5 0.5 0.6 0.6 0.6
I High estimate
A second approach to estimating public expenditure on 
drug-law offenders is to account for public expenditure on 
both sentenced and pre-trial drug-law offenders. Currently, 
there are no data available on the number of pre-trial prisoners 
whose main offence is a drug-law one. Therefore, to estimate 
this, the EMCDDA will assume that the proportion of 
sentenced drug-law offenders among sentenced prisoners is 
identical to the proportion of pre-trial drug-law offenders 
among all pre-trial offenders in prison.
Table 4 shows that, during the period 2000–10, pre-trial 
prisoners represented 28 % of total prisoners in the 22 
countries that submitted data. This proportion varied markedly 
between countries. For example, in Italy, Luxembourg, the 
Netherlands and Malta over 40 % of prisoners were pre-trial; 
while in Bulgaria, the Czech Republic, Germany, Ireland and 
Lithuania this proportion was 20 % or less.
When we apply the high-estimate model, the estimated 
annual public expenditure on drug-law offenders in prison for 
these 22 countries during the period 2000–10 increases to 
0.05 % of GDP, compared with 0.03% of GDP when the 
low-estimate model is applied (see Table 4).
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governments’ expenditure on drug-law offenders in prison 
would have ranged between EUR 3.7 billion and EUR 5.9 
billion.
Table 5 shows that, of 22 countries, four spent less than 
0.01 % of GDP on drug-law offenders in prison and 12 spent 
on average between 0.01 % and 0.03 % of GDP on drug-law 
offenders, if we account only for expenditure on sentenced 
prisoners (the low estimate). Thus, estimates exceed 0.03 % of 
GDP in six countries. If public spending on pre-trial prisoners 
is included (the high estimate), then the estimates exceeded 
0.03 % of GDP for 11 countries, reaching a maximum of 
approximately 0.08 % of GDP in two countries.
I Results
The low and the high estimates provide a range of figures. 
These suggest that public expenditure on drug-law offenders 
in prison as a proportion of GDP varied between 0.03 % and 
0.05 %  within the period 2000 and 2010, in 22 countries in 
Europe. Variations occurred across countries as a result of 
national differences in factors such as the crime rate, the legal 
framework, the judicial system, sentencing practices and also 
the proportion of pre-trial prisoners in the total population.
If we assume that, on average, the EU-27 public expenditure 
on drug-law offenders in prisons does not significantly differ 
from that of these 22 countries, then in 2010 the EU-27 
TABLE 4
Estimated public expenditure on total drug-law offenders in prisons (as a percentage of GDP)
Pre-trial prisoners 
(% of prison 
population)
Estimated proportion of sentenced  
drug-law offenders
Estimated public expenditure on  
drug-law offenders (% GDP)
% of total (pre-trial and 
sentenced) prisoners
% of sentenced 
prisoners
Low estimate High estimate
2000–10 
average
2010
2000–10 
average
2010
2000–10 
average
2010
2000–10 
average
2010
2000–10 
average
2010
Bulgaria 17  7.6  3.8  6.7  4.5  8.0 0.006 0.01 0.007 0.011
Czech Republic 17 11.2  6.6  5.8  7.6  6.6 0.013 0.01 0.015 0.012
Denmark 31 35.7 14.8 13.5 21.8 20.9 0.025 0.02 0.037 0.037
Germany 20 16.0 12.0 12.4 14.8 14.8 0.013 0.01 0.016 0.015
Estonia 27 22.6  7.4 12.7  9.3 16.5 0.023 0.03 0.029 0.038
Ireland 16 15.2 15.3 18.9 18.3 22.2 0.035 0.04 0.042 0.051
Greece 28 31.2 29.0 36.0 41.0 52.3 0.021 0.02 0.030 0.032
Spain 26 21.0 20.8 22.1 28.4 28.0 0.027 0.04 0.038 0.048
Italy 47 45.8 18.7 20.8 35.2 38.4 0.043 0.05 0.082 0.087
Cyprus 20 44.6 16.5 15.6 20.9 28.1 0.015 0.02 0.019 0.031
Latvia 34 28.4  6.8 10.7  9.4 15.0 0.020 0.02 0.027 0.024
Lithuania 18 17.8  3.8  0.8  4.4  1.0 0.008 0.00 0.009 0.002
Luxembourg 47 42.6 17.8 20.7 33.0 36.1 0.020 0.02 0.037 0.043
Hungary 28 32.5  1.5  2.1  2.1  3.1 0.003 0.00 0.004 0.005
Malta (1) 42 69.5 23.9 16.3 41.1 53.4 0.038 0.03 0.057 0.084
Netherlands 63 50.4  7.7  8.6 20.8 17.3 0.029 0.04 0.077 0.072
Portugal 25 11.0 22.6 16.8 30.4 21.5 0.041 0.03 0.055 0.040
Slovenia 34 15.4  6.9  6.6 10.5  9.6 0.007 0.01 0.010 0.011
Finland 18 22.6 13.5 12.0 16.0 15.0 0.018 0.02 0.021 0.020
Sweden 22 21.0 19.2 22.1 24.7 40.8 0.043 0.05 0.055 0.066
United Kingdom 18 22.4 13.1 12.6 16.1 14.9 0.041 0.05 0.051 0.056
Norway 24 30.5 23.7 18.2 30.4 26.2 0.027 0.02 0.035 0.035
EU-22 28 27.9 14.3 14.9 19.2 20.1 0.030 0.03 0.05 0.05
(1) There are no data for 2010. The latest available data concern 2009.
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TABLE 5
Estimates of public expenditure on drug-law offenders in 
prison for the period 2000–10 (as a percentage of GDP)
min. max. 0.01 % ≤
0.01 % > & 
≤ 0.03 %
> 0.03 %
Bulgaria 0.006 0.007 X
Czech Republic 0.013 0.023 X
Denmark 0.025 0.037 X X
Germany 0.013 0.016 X
Estonia 0.023 0.029 X
Ireland 0.035 0.042 X
Greece 0.021 0.030 X
Spain 0.027 0.038 X X
Italy 0.043 0.082 X
Cyprus 0.015 0.019 X
Latvia 0.020 0.027 X
Lithuania 0.008 0.009 X
Luxembourg 0.020 0.037 X
Netherlands 0.029 0.077 X X
Hungary 0.003 0.004 X
Malta 0.038 0.057 X
Portugal 0.041 0.055 X
Slovenia 0.007 0.010 X
Finland 0.018 0.021 X
Sweden 0.043 0.055 X
United Kingdom 0.041 0.051 X
Norway 0.027 0.035 X X
EU-22 0.03 0.05 X X
I Comparison with existing national estimates
The estimates provided by the model can be broadly 
compared with existing national estimates of public 
expenditure on drug-law offenders in prison or can be 
analysed from the perspective of public expenditure on drug 
supply reduction activities overall. Public expenditure on 
supply reduction activities includes spending on police forces, 
law courts and prisons. There are two approaches to 
measuring overall expenditure on drug supply activities most 
frequently taken by countries estimating expenditure on 
supply reduction. The first, proposed by Reuter (2006), 
includes expenditure on prisons and says that public 
expenditure on drug supply reduction is related to law 
enforcement (i.e. includes ‘Enforcement programmes: 
programmes aimed at traffickers and producers to shift up the 
supply curve for drugs […]; programmes aimed at users and 
retailers raise the transaction costs of buying drugs’). The 
second classification was set up by the EMCDDA (2008) and 
is based on the COFOG classification of public expenditures. 
In this case, public expenditures on supply reduction activities 
are included in the ‘Public order and safety’ class of 
expenditure and includes expenditure on prisons.
It should be noted, however, that national estimates are not 
fully comparable either with one another or with EMCDDA 
estimates, whatever the classification of public expenditures 
applied. They provide estimates for different years, use 
different methodologies and may cover slightly different types 
of expenditure. Therefore, the results presented in Table 6 
cannot serve as a definitive benchmark for this analysis; they 
can only suggest indicative estimated ranges. Furthermore, 
when national estimates concern either public expenditure on 
law enforcement or public order and safety, they mostly cover 
total public expenditure on drug supply reduction activities 
and have a much wider scope than prison expenditure. Since 
they cover expenditure other than on prisons, these estimates 
should be higher.
Table 6 shows that, for 9 out of 12 countries, EMCDDA 
estimates of public expenditure on drug-law offenders in 
prison are significantly lower than the national estimates of 
public expenditure on drug supply reduction, and represent 
between 8 % and 81 % of these national estimates. In three 
countries, our estimates were not compatible, as they were 
larger than the overall estimate for supply reduction. An 
explanation is available for Cyprus, where the national 
estimate considered only wages and not expenditures such as 
the amortisation of the capital invested in prison 
infrastructures, energy, etc. (National Focal Point, 2011) (10). 
There is no information available concerning the methodology 
used by Latvia and Portugal, and therefore the discrepancies 
cannot be explored.
A small number of countries also provided an estimate of 
public expenditure on drug-law offenders in prison; these are 
more directly comparable with the estimates provided in this 
report. In most cases, national estimates are higher than those 
produced in this report. This can be explained for the UK and 
the Czech Republic, as national estimates also included 
expenditure on prisoners who had committed an offence 
while under the influence of drugs (i.e. not only drug-law 
offenders). In the Netherlands (2003) and Sweden, national 
estimates included spending on drug-law offenders in 
custody, on conditional release and on probation, whereas the 
COFOG data in the current study classify these expenses 
under ‘Law courts’ rather than ‘Prisons’. For the other 
countries, either the method applied is significantly different 
from the one suggested here or there is no information 
available. Therefore, all in all, although national estimates do 
not fit particularly well with EMCDDA estimates, these results 
were to be expected as the parameters and assumptions 
differed markedly.
(10)  This study estimated public expenditure on drug-law offenders in prisons by 
multiplying the average salary of the law enforcement officers involved by the 
number of officers in charge of monitoring drug-law offenders in prison.
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estimates represent. Table 7 shows that in 2010 public 
expenditure on drug-law offenders in prison ranged between 
0.07 % and 0.09 % of the total public expenditure of the 22 
European countries. The yearly average over the period 
2000–10 varied more. In the early 2000s, when data were 
only available for a few countries, the proportion was 
0.09 %–0.12 %. After 2001, the proportion declined slightly 
and varied between 0.06 % and –0.9 % of total public 
expenditure.
The number of detainees for drug-law offences varied in many 
countries during the period 2000–10 (see Annex 1), and it is 
interesting to examine whether or not public expenditure on 
drug-law offenders varied accordingly. Annex 2 and Annex 3 
show that neither the real growth (after correction for inflation) 
nor the nominal growth of this estimated public expenditure 
showed a clear pattern, with the exception of 2009 and 2010, 
when more than half of the countries registered decreases in 
expenditure, probably associated with public-sector austerity 
measures following the economic recession of 2008.
Estimates provided by the model and by the existing national 
estimates for public expenditure on drug-law offenders in 
prison are presented in Table 6. There is no obvious agreement 
between the estimates provided in this study and those 
produced at national level; however, methodological 
differences make it difficult to draw direct comparisons.
In future, it would be advantageous to have access to further 
information about the methods used in national estimates, 
since this would make the analysis of results more meaningful 
and would facilitate useful comparisons with other studies.
I  Expenditures on drug-law offenders in prison and total public expenditures
Until now, this report has considered estimates of public 
expenditure on drug-law offenders in prison only as a 
proportion of GDP. Another way to look at the subject is to 
consider what proportion of total public expenditure these 
TABLE 6
Estimates of public expenditure on drug supply reduction and on drug-law offenders: national estimates and EMCDDA 
estimates (as a percentage of GDP)
Year
National estimates EMCDDA estimates
Item
Supply reduction 
(% GDP)
Prisons (% GDP) Prisons (% GDP)
Low High Low High Low High
Czech Republic 2005 Public order and safety (1) 0.13 0.036 0.010 0.011
Germany 2006 Public order and safety (2) 0.14 0.18 0.021 0.037 0.013 0.015
Italy 2009 Law enforcement (3) 0.13 0.041 0.084
Cyprus 2010 Law enforcement (4) 0.01 0.015 0.019
Latvia 2008 Public order and safety (5) 0.003 0.002 0.020 0.027
Luxembourg 2009 Public order and safety (6) 0.06 0.044 0.047
Hungary 2007 (*) Law enforcement (7) 0.03 0.003 0.004
Netherlands 2003 Law enforcement (8) 0.35 0.118 0.031 0.097
2006 0.04 (9) 0.025 0.067
Portugal 2005 Public order and safety (10) 0.04 0.040 0.052
Finland 2009 Public order and safety (11) 0.04 0.016 0.019
Sweden 2002 Law enforcement (12) 0.12 0.30 0.048 0.037 0.047
United Kingdom 2005 Public order and safety (13) 0.29 0.08 0.045 0.054
(*) The EMCDDA’s estimates concern 2008, while national estimates concern 2007. (7) NR 2009, Hungary.
(1) NR 2007, Czech Republic. (8) Righter (2006).
(2) Mostardt et al. (2010). (9) Moolenar, 2009.
(3) NR 2011, Italy. (10) EMCDDA, 2008.
(4) NR 2011, Cyprus. (11) NR 2011, Finland.
(5) Vanags and Zasova (2010). (12) Ramstedt, 2006.
(6) NR 2010, Luxembourg. (13) NR 2007, United Kingdom.
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TABLE 7
Estimated public expenditure on drug-law offenders in prison (as a percentage of total public expenditure)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 (2000–10)
Low High Low High Low High Low High Low High Low High Low High Low High Low High Low High Low High Low High
Bulgaria 0.002 0.002 0.001 0.003 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.03 0.01 0.02
Czech 
Republic
0.02 0.02 0.02 0.03 0.03 0.04 0.03 0.04 0.05 0.06 0.03 0.03 0.02 0.03 0.03 0.03
Denmark 0.04 0.06 0.04 0.06 0.04 0.05 0.05 0.07 0.06 0.08 0.05 0.08 0.06 0.08 0.05 0.08 0.05 0.08 0.04 0.06 0.05 0.07
Germany 0.03 0.03 0.03 0.03 0.03 0.04 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Estonia 0.01 0.01 0.03 0.04 0.08 0.07 0.03 0.02 0.04 0.05 0.04 0.05 0.05 0.07 0.17 0.23 0.09 0.11 0.07 0.09 0.06 0.08
Ireland 0.08 0.10 0.00 0.00 0.07 0.09 0.08 0.10 0.09 0.11 0.09 0.11 0.06 0.08 0.07 0.08
Greece 0.03 0.04 0.06 0.08 0.04 0.06 0.04 0.06
Spain 0.07 0.08 0.08 0.10 0.07 0.09 0.07 0.09 0.05 0.08 0.06 0.08 0.07 0.09 0.07 0.10 0.07 0.11 0.06 0.09 0.08 0.10 0.07 0.09
Italy 0.10 0.19 0.10 0.18 0.10 0.18 0.11 0.19 0.11 0.17 0.11 0.17 0.06 0.14 0.06 0.14 0.07 0.17 0.08 0.16 0.09 0.17 0.09 0.17
Cyprus 0.03 0.03 0.02 0.03 0.02 0.03 0.03 0.04 0.04 0.05 0.05 0.06 0.04 0.05 0.03 0.04 0.04 0.07 0.03 0.04
Latvia 0.06 0.08 0.05 0.07 0.04 0.06 0.04 0.05 0.05 0.07
Lithuania 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.02 0.03 0.02 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.00 0.00 0.02 0.03
Luxembourg 0.04 0.08 0.04 0.08 0.03 0.07 0.02 0.04 0.03 0.07 0.06 0.11 0.07 0.13 0.07 0.13 0.07 0.12 0.06 0.11 0.06 0.10 0.05 0.09
Hungary 0.001 0.003 0.001 0.004 0.002 0.01 0.001 0.01 0.001 0.005 0.002 0.006 0.001 0.005 0.002 0.007 0.001 0.01
Malta 0.01 0.12 0.01 0.14 0.01 0.08 0.01 0.09 0.005 0.07 0.0001 0.07 0.01 0.09
Netherlands 0.07 0.22 0.07 0.22 0.07 0.18 0.05 0.14 0.06 0.16 0.06 0.17 0.06 0.19 0.06 0.18 0.07 0.16 0.06 0.18
Portugal 0.12 0.18 0.13 0.19 0.13 0.19 0.09 0.11 0.08 0.11 0.08 0.10 0.06 0.08 0.06 0.08 0.06 0.08 0.09 0.12
Slovenia 0.01 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.01 0.02
Finland 0.04 0.05 0.04 0.05 0.04 0.05 0.04 0.04 0.03 0.04 0.03 0.04 0.03 0.04 0.03 0.03 0.03 0.04 0.04 0.04
Sweden 0.06 0.08 0.07 0.08 0.07 0.09 0.07 0.09 0.08 0.10 0.07 0.09 0.08 0.10 0.10 0.13 0.11 0.14 0.10 0.13 0.08 0.10
United 
Kingdom
0.10 0.12 0.09 0.11 0.08 0.10 0.09 0.12 0.10 0.12 0.10 0.12 0.10 0.12 0.10 0.13 0.09 0.12 0.09 0.11 0.09 0.11 0.09 0.12
Norway 0.06 0.08 0.05 0.07 0.07 0.07 0.06 0.08 0.06 0.08 0.06 0.08 0.09 0.11 0.06 0.08 0.07 0.09 0.05 0.08 0.06 0.08
EU-22 0.09 0.12 0.08 0.11 0.06 0.08 0.07 0.09 0.07 0.09 0.07 0.09 0.06 0.09 0.06 0.09 0.06 0.09 0.06 0.08 0.07 0.09 0.07 0.09
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two years, when the number of countries with available 
information was limited, these proportions of GDP remained 
stable. When applying these percentages to the whole EU for 
the year 2010, public expenditure on drug-law offenders in 
prison is estimated to have been within the range of EUR 3.7 
billion to EUR 5.9 billion.
Over the period 2000–10, it is estimated that 12 out of the 22 
countries spent on average between 0.01 % and 0.03 % of 
GDP on drug offenders in prisons, if we account only for 
expenditure on sentenced prisoners. If public spending on 
pre-trial prisoners is included, then the estimates exceeded 
0.03 % of GDP in 10 countries, reaching a maximum of 
approximately 0.08 % of GDP in 2 countries.
Overall, there is no obvious agreement between the EMCDDA 
estimates and national estimates. However, differences are to 
be expected because the estimates used different methods 
and often involved slightly different definitions of expenditure. 
Further information about the methods used in arriving at 
national estimates would be advantageous to facilitate the 
comparison of estimates.
The estimates provided by the model have been used in an 
analysis of public expenditure on drug-law offenders as a 
proportion of total national public expenditure. Since 2006, in 
the 22 countries for which data are available, the proportion of 
expenditure on drug-law offenders in prisons has varied within 
the range of 0.06 %–0.9 % of total public expenditure. It is not 
possible to define a clear trend over time, except in 2009 and 
2010. In those years, more than half of the countries 
registered decreases in expenditure, probably associated with 
public-sector austerity measures introduced by most 
European countries as a result of the economic recession of 
2008.
While recognising the limitations imposed by currently 
available data sets, this exercise aims at enabling a step 
forward in the estimation of drug-related public expenditure in 
Europe. It provides an example of a methodology that can be 
used to arrive at comparable national estimates and presents 
a range of estimates of European public expenditure on 
drug-law offenders in prison. For the sake of accuracy, more 
complete data sets with further information on the 
characteristics of prisoners and their costs would be a 
valuable asset.
I Conclusion
The EMCDDA aims to provide support to EU Member States 
by analysing examples of data sources and models that can 
be or have been used with success to estimate drug-related 
public expenditure on different components of drug policy. As 
a first step, the EMCDDA has estimated the amount of annual 
public expenditure on drug-law offenders in prisons in Europe, 
using harmonised data sources and a simple model. Based on 
data provided by Eurostat and the Council of Europe, the 
model applies the proportion of sentenced prisoners who 
have a drug-law offence as their main offence to total public 
expenditure on prisons.
However, there are limitations in the data. For example, data 
are missing for 8 of the 30 countries that participate in the 
EMCDDA’s Reitox network and, for the remaining 22, data 
series are not always complete for the period 2000–10 
(though there were improvements in the data submitted 
during this period). The penal statistics provided by the 
Council of Europe have some additional limitations, such as 
the non-application of the ‘main offence rule’ in some 
countries and the lack of information about the main offence 
for which pre-trial prisoners are prosecuted. Public 
expenditure data from Eurostat also face some harmonisation 
issues, associated with the difficulty of harmonising the 
classification of public expenditure by main purpose and with 
different national accountancy practices. Furthermore, there 
are no data available for the lengths of periods of 
imprisonment or the proportion of prisoners under special 
security measures according to type of offence. These data 
limitations reduce the accuracy of estimates and demand 
caution when analysing results. Nevertheless, first estimates 
appear to be promising.
Within this framework, the EMCDDA has calculated a range of 
estimates of public expenditures on drug-law offenders in 
prison. The low estimate considers only those prisoners who 
have been sentenced for a drug-law offence. The high 
estimate also includes pre-trial prisoners who may be 
sentenced for a drug-law offence (assuming that the 
proportion of drug-law offenders among pre-trial prisoners is 
identical to that of drug-law offenders among sentenced 
prisoners). Applying these low and high estimates, between 
2000 and 2010, public expenditure on drug-law offenders in 
22 European countries is estimated to have been within the 
range of 0.03 %–0.05 % of GDP. With the exception of the first 
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Note: No data available for Poland and Austria.
Source: Aebi and Delgrand (2012), ‘Annual Penal Statistics of the Council of Europe SPACE I, survey 2010’.
EMCDDA PAPERS I Estimating public expenditure on drug-law offenders in prison in Europe
19 / 22
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Bulgaria 64 % 153 % 29 % -20 % 31 % 2 %
Czech Republic 58 % 10 % 69 % -44 % -13 %
Denmark 6 % -10 % 24 % 22 % -3 % 6 % -10 % 2 % -2 %
Germany 3 % 4 % 0 % -5 % 1 % 1 % 0 % -1 %
Estonia 169 % -56 % 20 % 18 % 54 % 265 % -50 % -3 %
Ireland 39 % 22 % 17 % 9 % 2 %
Greece
Spain 18 % -5 % -3 % -12 % 17 % 15 % 2 % 9 % -1 % -2 %
Italy -1 % 9 % 13 % -5 % -2 % -44 % -4 % 33 % 10 % 15 %
Cyprus -12 % -1 % 47 % 44 % 56 % 1 % -21 % -17 %
Latvia -9 % -24 % 2 %
Lithuania 23 % 58 % 4 % 29 % 0 % 21 % 31 % 29 % 4 % -90 %
Luxembourg 10 % -10 % -29 % 28 % 121 % 17 % 9 % 4 % -9 % -2 %
Hungary 39 % 126 % -23 % -11 % -20 % 32 %
Malta 19 % -37 % -24 % -12 %
Netherlands 1 % 0 % -19 % 10 % 4 % 14 % -4 % 27 %
Portugal 8 % 2 % -5 % 3 % -25 % 6 % 4 %
Slovenia -8 % 3 % -6 % 8 % 14 % -7 % 16 % -11 % -6 % 19 %
Finland 13 % -13 % -3 % -4 % 12 % -13 % 3 %
Sweden 18 % 6 % 4 % 8 % -1 % 14 % 24 % -8 % 5 %
United Kingdom 3 % -5 % 13 % 15 % 8 % -3 % 10 % -16 % -14 % 6 %
Norway 27 % -19 % 13 % 4 % 49 % -26 % 8 % -10 %
I  Annex 2
Estimated growth of public expenditure on sentenced drug-law offenders in prison, corrected for inflation (based on the 
proportion of sentenced drug-law offenders to total sentenced and pre-trial prisoners; growth rates, deflated 1995 = 100)
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2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Bulgaria 73 % 158 % 39 % -11 % 34 % 5 %
Czech Republic 61 % 13 % 80 % -44 % -12 %
Denmark 9 % -8 % 25 % 24 % -1 % 8 % -7 % 3 % 0 %
Germany 4 % 5 % 1 % -3 % 3 % 4 % 0 % 0 %
Estonia 173 % -55 % 25 % 23 % 64 % 304 % -50 % 0 %
Ireland 45 % 26 % 21 % 7 % 0 %
Greece
Spain 21 % -1 % 0 % -10 % 21 % 19 % 5 % 14 % -1 % 0 %
Italy 1 % 11 % 16 % -2 % 1 % -42 % -2 % 38 % 11 % 17 %
Cyprus -9 % 1 % 50 % 47 % 59 % 5 % -21 % -15 %
Latvia 5 % -21 % 0 %
Lithuania 25 % 58 % 3 % 30 % 2 % 26 % 39 % 43 % 8 % -90 %
Luxembourg 13 % -8 % -27 % 32 % 129 % 21 % 12 % 9 % -9 % 1 %
Hungary 51 % 138 % -19 % -4 % -17 % 38 %
Malta 22 % -35 % -22 % -10 %
Netherlands 3 % 1 % -18 % 12 % 6 % 17 % -3 % 28 %
Portugal 11 % 5 % -2 % 6 % -23 % 5 % 5 %
Slovenia 0 % 11 % 0 % 12 % 17 % -5 % 21 % -6 % -5 % 21 %
Finland 13 % -12 % -2 % -3 % 17 % -11 % 4 %
Sweden 21 % 9 % 5 % 8 % 0 % 16 % 28 % -6 % 7 %
United Kingdom 4 % -4 % 15 % 16 % 10 % 0 % 13 % -13 % -12 % 10 %
Norway 30 % -18 % 15 % 7 % 50 % -23 % 10 % -8 %
I  Annex 3
Estimated nominal growth of public expenditure on sentenced drug-law offenders in prison (based on the proportion of 
sentenced drug-law offenders to total sentenced and pre-trial prisoners; growth rates, nominal terms)
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